Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Scientific Reports|January 8, 2025
hsa_circ_0008305 facilitates the malignant progression of hepatocellular carcinoma by regulating AKR1C3 expression and sponging miR-379-5pShenglan Huang, Kan Liu, Yongkan Xu, et al.
Clinical and Experimental Medicine|May 31, 2026
Current advances in immunotherapy for KRAS-Mutant pancreatic cancerMan Li, Xiao Wang, Pengen Li, et al.
Journal of Separation Science|July 2, 2011
Counter-current chromatographic method for preparative scale isolation of picrosides from traditional Chinese medicine Picrorhiza scrophulariifloraZhe Chen, Jianbing Wu, Wei Shen, et al.
Drug Design, Development and Therapy|August 28, 2025
Therapeutic Targeting of PPARγ in Nonalcoholic Fatty Liver Disease: Efficacy, Safety, and Drug DevelopmentZhanyi Zhou, Rijuan Jin, Yuting Gu, et al.
International Journal of Environmental Research and Public Health|January 8, 2023
Determinants and the Moderating Effects of Individual Characteristics on Autonomous Vehicle Adoption in ChinaTianpei Tang, Xiwei Wang, Jianbing Wu, et al.
Frontiers in Medicine|September 19, 2022
Efficacy and safety of hepatic arterial infusion chemotherapy combined with programmed cell death protein-1 antibody and lenvatinib for advanced hepatocellular carcinomaYongkang Xu, Shumin Fu, Ye Mao, et al.
Frontiers in Molecular Biosciences|September 2, 2022
A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinomaShenglan Huang, Cairong Dong, Jian Zhang, et al.
European Journal of Medicinal Chemistry|November 6, 2023
Advances in nitric oxide regulators for the treatment of ischemic strokeJianbing Wu, Jian Jia, Duorui Ji, et al.
Biochemical and Biophysical Research Communications|February 13, 2018
Long non-coding RNA 00312 downregulates cyclin B1 and inhibits hepatocellular carcinoma cell proliferation in vitro and in vivoJianbing Wu, Xiaoxin Zhou, Yilei Fan, et al.
Functional & Integrative Genomics|November 4, 2025
DDX1 facilitates lenvatinib resistance in hepatocellular carcinoma through regulating ephrin-A3 and activating the Wnt/β-catenin signaling pathwayShenglan Huang, Hua Wang, Shumin Fu, et al.
Pageof 14